Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

By Semeniuk-Wojtaś Aleksandra   Lubas Arkadiusz   Stec Rafał   Szczylik Cezary   Niemczyk Stanisław  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2073-2073

MDPI

Access to resources Recommend Favorite

Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells

By Librizzi Mariangela   Spencer John   Luparello Claudio  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-07 ,pp. : 1235-1235

MDPI

Access to resources Recommend Favorite

Differentiated Thyroid Cancer—Treatment: State of the Art

By Schmidbauer Benedikt   Menhart Karin   Hellwig Dirk   Grosse Jirka  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1292-1292

MDPI

Access to resources Recommend Favorite

Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?

By Mittica Gloria   Genta Sofia   Aglietta Massimo   Valabrega Giorgio  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1169-1169

MDPI

Access to resources Recommend Favorite

Study on Biopharmaceutics Classification and Oral Bioavailability of a Novel Multikinase Inhibitor NCE for Cancer Therapy

By Yang Yang   Fan Chun-Mei   He Xuan   Ren Ke   Zhang Jin-Kun   He Ying-Ju   Yu Luo-Ting   Zhao Ying-Lan   Gong Chang-Yang   Zheng Yu   Song Xiang-Rong   Zeng Jun  

International Journal of Molecular Sciences, Vol. 15, Iss. 5, 2014-04 ,pp. : 7199-7212

MDPI

Access to resources Recommend Favorite